4.2 Article

A Preoperative Multimarker Approach to Evaluate Acute Kidney Injury After Cardiac Surgery

Journal

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Volume 31, Issue 3, Pages 837-846

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.jvca.2016.10.005

Keywords

acute kidney injury; cardiac surgery; preoperative biomarkers; risk prediction

Funding

  1. NTNU-Norwegian University of Science and Technology [249/2015]
  2. Norwegian Council on Cardiovascular Diseases [2010.DR.034, 2011.DR.054]
  3. Liaison Committee [7394]
  4. St. Olays University Hospital
  5. Simon Fougner Hartmann Family Foundation, Dragor, Denmark

Ask authors/readers for more resources

Objective: To investigate whether a multimarker strategy combining preoperative biomarkers representing distinct pathophysiologic pathways enhances preoperative risk assessment of acute kidney injury after cardiac surgery (CSA-AKI) and increases knowledge of underlying pathogenesis. Design: Prospective, cohort study. Setting: Single-center tertiary referral hospital. Participants: The study comprised 1,015 adults undergoing cardiac surgery with cardiopulmonary bypass. Interventions: CSA-AKI was defined as >= 50% increase in serum creatinine concentration, absolute increase >= 26 mu mol/L, or new requirement for dialysis. Preoperative and perioperative information until hospital discharge was recorded. Preoperative plasma levels of C-reactive protein, terminal complement complex, neopterin, lactoferrin, N-terminal pro-brain natriuretic peptide, and cystatin C were determined using enzyme immunoassays. Biomarkers were selected based on causal hypotheses of underlying mechanisms and were related to inflammatory, hemodynamic, or renal signaling pathways. Measurements and Main Results: One hundred patients (9.9%) developed CSA-AKI. Higher baseline plasma concentrations of neopterin and N-terminal pro-brain natriuretic peptide were associated independently with CSA-AKI (p = 0.04 and p < 0.001, respectively). Lower baseline plasma lactoferrin concentrations were observed in patients with CSA-AKI (p = 0.05). Compared with clinical risk assessment, addition of these biomarkers provided a slight, but significant, increment in predictive utility (area under the curve 0.81-0.83, likelihood ratio test p < 0.001). A net of 12% of patients were reclassified correctly, and improved prediction was demonstrated, especially in patients with intermediate risk (56% correct reclassification). Conclusions: Preoperative hemodynamic, renal, and immunologic function play central roles in the pathogenesis of CSA-AKI. These findings add evidence to the potential of a multimarker approach to improve preoperative prediction of CSA-AKI. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available